Skip to content

A pilot psychedelic psychopharmacology elective.

Joseph Cusimano

Currents in Pharmacy Teaching and Learning May 2022 DOI: 10.1016/j.cptl.2022.04.019 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 12
Population Second- and third-year pharmacy students
Keywords Elective Psychedelic Psychopharmacology
Key findings The authors report that a pilot psychedelic psychopharmacology elective, delivered synchronously online to 12 pharmacy students, was feasible for a single instructor and well-received by students. They describe it as a success that provides a framework for future courses in this therapeutic area.

Abstract

There is renewed research attention on the use of psychedelic drugs to treat psychiatric illnesses. If psychedelic drugs are approved for medical use in the United States, patients, professionals, and policy makers will look to pharmacists as medication experts for advice on the safe, effective, and ethical use of these substances. To help prepare a future generation of pharmacists in this therapeutic area, a psychedelic psychopharmacology elective was developed and piloted. Broadly, the objectives of the course were to train students to (1) analyze scientific literature, (2) engage in ethical discussions, and (3) make evidence-based clinical recommendations about the use of psychedelics. The pilot elective course was delivered synchronously online to 12 second- and third-year pharmacy students during spring 2021. Activities included journal clubs, textbook reading assignments, reflective structured dialogues, a monograph, and a term paper. The course was feasible for a single instructor and well-received by students. A mix of instructor-directed and self-directed learning approaches were utilized. The pilot psychedelic psychopharmacology elective was a success, providing a framework for future courses.

Citations in the library